GUARD Share Price Performance
SEK 1.47
-21.34 (-93.57%)
Price SEK 1.47
Share PriceSEK 1.47
We Think Guard Therapeutics International (STO:GUARD) Can Afford To Drive Business Growth
Sep 22
Guard Therapeutics International AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
GUARD Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Guard Therapeutics International AB (publ) Key Details
About GUARD
- Founded
- 2008
- Employees
- 12
- CEO
- WebsiteView website
Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.
